Pregabalin + Methylcobalamin + Alpha Lipoic Acid + Pyridoxine Hydrochloride + Folic AcidThird Party Manufacturing in India

Pregabalin, Methylcobalamin, Alpha Lipoic Acid, Pyridoxine Hydrochloride, and Folic Acid is a rationally designed five-component fixed-dose combination that targets neuropathic pain through complementary pharmacological, neurotrophic, and antioxidant mechanisms. Pregabalin, a structural analogue of gamma-aminobutyric acid, binds with high affinity to the alpha-2-delta auxiliary subunit of voltage-gated calcium channels in the central nervous system. This binding reduces depolarisation-induced calcium influx into presynaptic nerve terminals, thereby decreasing the release of excitatory neurotransmitters including glutamate, norepinephrine, calcitonin gene-related peptide, and substance P. By dampening the hyperexcitability of spinal cord dorsal horn neurons and supraspinal pain processing centres, pregabalin provides rapid symptomatic relief from neuropathic pain. Methylcobalamin, the active coenzyme form of vitamin B12, directly participates in the methionine synthase reaction where it donates methyl groups for the conversion of homocysteine to methionine, supporting the production of S-adenosylmethionine essential for myelin phospholipid synthesis and axonal transport of neurotrophic factors. Alpha Lipoic Acid acts as a potent lipophilic antioxidant that scavenges reactive oxygen species, chelates transition metals, and regenerates endogenous antioxidants including glutathione and vitamin C. It improves nerve conduction velocity and endoneurial blood flow by reducing oxidative damage to peripheral nerves and dorsal root ganglia. Pyridoxine Hydrochloride, as the precursor of pyridoxal-5-phosphate, serves as an essential cofactor for cystathionine-beta-synthase in the transsulfuration pathway, diverting homocysteine away from neurotoxic pathways. Folic Acid provides 5-methyltetrahydrofolate that supplies methyl groups for the remethylation of homocysteine to methionine. Together, pregabalin addresses pain signaling while the vitamin and antioxidant components support nerve repair and reduce oxidative neuronal injury.

Therapeutic Uses

This five-component combination is prescribed for the management of neuropathic pain conditions:

• Diabetic Peripheral Neuropathy: The combination is widely prescribed for the burning, tingling, numbness, and lancinating pain associated with diabetic neuropathy. Pregabalin provides rapid symptomatic relief while methylcobalamin, alpha lipoic acid, pyridoxine, and folic acid support nerve regeneration and reduce oxidative damage to peripheral nerves.
• Lumbar and Cervical Radiculopathy: Effective for nerve root compression-related pain arising from degenerative spinal conditions, providing both pain modulation and neurotrophic support.
• Postherpetic Neuralgia: Reduces persistent nerve pain following herpes zoster infection through combined central pain modulation and peripheral nerve repair mechanisms.
• Trigeminal Neuralgia: Used as part of multimodal therapy for this severe facial pain condition where pregabalin dampens paroxysmal discharges and B vitamins support cranial nerve health.
• Chemotherapy-Induced Peripheral Neuropathy: Addresses dose-limiting neuropathic side effects of platinum-based and taxane chemotherapies through pregabalin's pain-modulating effects and the neuroprotective properties of B vitamins and alpha lipoic acid.
• HIV-Associated Neuropathy: Provides symptomatic relief and neurotrophic support for peripheral neuropathy associated with HIV infection and antiretroviral therapy.

Why Manufacturers Choose This Combination

This five-component neuropathic pain combination addresses one of the largest therapeutic gaps in Indian medicine — diabetic neuropathy — where over 77 million people with diabetes and approximately 50 percent developing neuropathy create enormous pharmaceutical demand. The combination offers prescribers a comprehensive single-capsule solution that addresses both pain symptoms and underlying nerve health, reducing the need for multiple separate prescriptions and improving patient compliance. Indian manufacturers benefit from readily available APIs for all five components with established supply chains and DMF filings. The product commands strong demand from physician specialists including neurologists, diabetologists, and orthopedicians, as well as from PCD franchise networks and export markets. This makes the combination one of the most commercially viable neuropathic formulations for third party manufacturing in India.

⚠️ Note: Methylcobalamin strength was not provided in the source data. Standard 500mcg has been used. Please confirm the intended methylcobalamin strength with the client.